Exchange Announces Preliminary Designation of Jeonjin Bio Pharm as a Non-Compliant Disclosure Corporation Due to Disclosure Failures...
The Korea Exchange KOSDAQ Market Division announced on the 11th that it has given advance notice of designation as an unfaithful disclosure corporation to Jeonjin Bio Pharm due to failure to disclose and reversal of disclosure.
The deadline for the decision is the 5th of next month.
Hot Picks Today
!["Stock Surges from 255,000 Won to Over 2.2 Million"... Up 773% Yet Set to Climb Higher [This Week's Hot Stock]](https://cwcontent.asiae.co.kr/asiaresize/93/2026042810243143173_1777339471.jpg)
"Stock Surges from 255,000 Won to Over 2.2 Million"... Up 773% Yet Set to Climb Higher [This Week's Hot Stock]
- "Nationwide Hoarding Frenzy Sparks Early Morning Store Rush... This Item's Resale Price Soars Hundreds of Times"
- Prime Minister Kim Minseok Wears Taegeukgi Badge Upside Down in China... Opposition Calls It a "National Embarrassment"
- "My Home Is in the 'Shuttle Zone' Near SK hynix, Please Cancel the Contract"... Surge in Cancellations Amid Soaring Home Prices [Real Estate AtoZ]
- Controversy Over "Want a Clean Woman" Ad: Linking Female Chastity to Disinfection Deemed Inappropriate, Dettol Issues Apology
The details include 5 cases of disclosure reversal and 1 case of failure to disclose.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Financial Stability Report] Bank of Korea Warns of 'Investing with Borrowed Funds, Leveraged ETFs'... "Losses Could Grow During Market Corrections"](https://cwcontent.asiae.co.kr/asiaresize/307/2026062411381121774_1782268691.jpg)